Effect of daily consumption of Lactobacillus reuteri CRL 1098 on cholesterol reduction in hypercholesterolemic subjects
Autor: | Malpeli, Agustina, Taranto, Maria Pia, Cravero, Ricardo C., Tavella, Marina, Fasano, Maria Victoria, Vicentin, Dimas, Ferrari, Guillermina, Magrini, Graciano, Hebert, Elvira Maria, Font, Graciela Maria, Varea, Ana María, Tavella, Julio Marcelo, González, Horacio F. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Otras Ingenierías y Tecnologías
Probiotics Functional foods CARDIOVASCULAR RISK Lactobacillus reuteri Hypercholesterolemia food and beverages INGENIERÍAS Y TECNOLOGÍAS Cardiovascular risk PROBIOTICS HIPERCHOLESTEROLAEMIA FUNCTIONAL FOOD Alimentos y Bebidas LACTOBACILLUS purl.org/becyt/ford/2 [https] Ciencias Médicas lipids (amino acids peptides and proteins) purl.org/becyt/ford/2.11 [https] |
Zdroj: | SEDICI (UNLP) Universidad Nacional de La Plata instacron:UNLP CONICET Digital (CONICET) Consejo Nacional de Investigaciones Científicas y Técnicas instacron:CONICET |
DOI: | 10.4236/fns.2015.617163 |
Popis: | The effect of daily consumption of a yogurt containing Lactobacillus reuteri CRL 1098 on the lipid profile of hypercholesterolemic subjects was evaluated by performing a prospective, randomized, double-blind, cross-over placebo controlled clinical study. Participants consumed daily a yogurt containing L. reuteri CRL 1098 or a placebo for four weeks, separated by a wash-out period. Total cholesterol, triacylglycerol, high-density (HDL) and low-density (LDL) lipoprotein levels were assessed at the beginning and at the end of each period. We found a statistically significant reduction of total (−7.86 g/dl) and LDL (−7.02 g/dl) cholesterol in absolute changes (before-after) as well as a decreasing trend in the group receiving the yogurt containing L. reuteri with respect to the placebo group, without detecting changes in HDL-cholesterol and triacylglycerol levels. Our results suggest that low amounts of yogurt (125 g/day) and low doses of the CRL 1098 strain (106 CFU) are sufficient to reduce total and LDL-cholesterol levels in hypercholesterolemic subjects. Facultad de Ciencias Médicas |
Databáze: | OpenAIRE |
Externí odkaz: |